Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …

Emerging efficacy data have led to the emergency use authorization or approval of COVID-
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …

The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …

As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …

Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …

Vaccination guidelines for patients treated for hematological diseases are typically
conservative. Given their high risk for severe COVID-19, it is important to identify those …

Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

Background Coronavirus disease 2019 (COVID-19) has affected> 210 million people
worldwide. An optimal therapeutic approach for COVID-19 remains uncertain, to date. Since …

COVID-19 has been spreading worldwide since late 2019. There is no definitive cure to
date. Global vaccination programs are urgently required to confer herd immunity, reducing …